Diffusion weighted magnetic resonance imaging demonstrates tumor response following palliative embolization of a recurrent shoulder plasmacytoma

World Journal of Surgical Oncology

Pál Novák Kaposi¹  Ildikó Kalina¹  Tamás Masszi²  Gábor Mikala⁴  Tamás Györke³  Lajos Rudolf Kozák⁵  Gábor Rudas⁵  Viktor Bérczi¹ 

[1] Department of Radiology and Oncotherapy, Semmelweis University, Üllői út 78/a, H-1082 Budapest, Hungary;Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary;Scanomed Ltd, Budapest, Hungary;Department of Haematology and Stem Cell Transplantation, St Istvan and St Laszlo Hospital, Budapest, Hungary;MRI Research Center, Szentágothai J Knowledge Center, Budapest, Hungary

关键词: palliative treatment;    bortezomib;    tumor response;    PET-CT;    MRI;    DWIBS;    transcatheter arterial embolization;    plasmacytoma;   

Others  :  1148203
DOI  :  10.1186/1477-7819-12-271

 received in 2014-05-18, accepted in 2014-08-06,  发布年份 2014

【 摘 要 】

We report the palliative embolization and functional imaging follow-up of a recurrent shoulder plasmacytoma. The multiple myeloma patient complained of severe pain and discomfort, while he could not tolerate further chemotherapy. The left shoulder lesion had earlier received a high dose of irradiation. Thus, the well-vascularized lesion was embolized via feeding arteries branching off from the left subclavian artery in two sessions. The patient’s symptoms rapidly improved post-embolization and the serum free light chain ratio stabilized at a lower level. The follow-up magnetic resonance image showed increased diffusivity in previously restricted tumor foci. This has negatively correlated with the decreased fludeoxyglucose uptake on PET, suggesting post-embolization necrosis.

【 授权许可】

   
2014 Bérczi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Feldman F, Casarella WJ, Dick HM, Hollander BA: Selective intra-arterial embolization of bone tumors. A useful adjunct in the management of selected lesions. Am J Roentgenol Radium Ther Nucl Med 1975, 123:130-139.
• [2]Boos N, Goytan M, Fraser R, Aebi M: Solitary plasma-cell myeloma of the spine in an adolescent. Case report of an unusual presentation. J Bone Joint Surg (Br) 1997, 79:812-814.
• [3]Matsuda M, Nakazawa T, Kizuki H, Matsumura K, Nakasu S, Handa J: Solitary plasmacytoma of the skull vault – case report. Neurol Med Chir (Tokyo) 1996, 36:388-392.
• [4]Horger M, Weisel K, Horger W, Mroue A, Fenchel M, Lichy M: Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results. Am J Roentgenol 2011, 196:W790-W795.
• [5]Messiou C, Giles S, Collins DJ, West S, Davies FE, Morgan GJ, Desouza NM: Assessing response of myeloma bone disease with diffusion-weighted MRI. Br J Radiol 2012, 85:e1198-e1203.
• [6]Kilciksiz S, Karakoyun-Celik O, Agaoglu FY, Haydaroglu A: A review for solitary plasmacytoma of bone and extramedullary plasmacytoma. Scientific World J 2012, 2012:895765.
• [7]Marciel AM, Van Zandt BL, Baxter AJ: Transcatheter arterial embolization for the palliation of painful bone lesions. Tech Vasc Interv Radiol 2011, 14:141-149.
• [8]Ginat DT, Mangla R, Yeaney G, Johnson M, Ekholm S: Diffusion-weighted imaging for differentiating benign from malignant skull lesions and correlation with cell density. Am J Roentgenol 2012, 198:W597-W601.
• [9]Agarwal A, Chirindel A, Shah BA, Subramaniam RM: Evolving role of FDG PET/CT in multiple myeloma imaging and management. Am J Roentgenol 2013, 200:884-890.
• [10]Byun BH, Kong CB, Lim I, Choi CW, Song WS, Cho WH, Jeon DG, Koh JS, Lee SY, Lim SM: Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma. J Nucl Med 2013, 54:1053-1059.